Success Story: EB-1A Approved in Just 19 Days under Premium Processing for an Advanced Medical Imaging Researcher
Client’s Testimonial:
"Thank you so much for the help from your team. It is a great pleasure to work with your team."
On August 4th, 2026, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Associate in the Field of Advanced Medical Imaging (Approval Notice).
General Field: Advanced Medical Imaging
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: China
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: August 4th, 2026
Processing Time: 19 days (Premium Processing Requested)
Case Summary:
We are pleased to share that we successfully secured approval of an I-140 EB-1A petition for a client in the field of advanced medical imaging. The petition was filed with premium processing and approved in just 19 days. The case demonstrated that the client qualified as an individual of extraordinary ability through original contributions of major significance, scholarly authorship, service as a judge of the work of others, and a sustained record of national and international recognition. Rather than relying on numbers alone, we organized the evidence to explain why the client's achievements reflected lasting influence within a highly specialized area of research.
The client holds a Ph.D. and is currently conducting research in the United States on advanced electronic materials and devices for medical imaging technologies. We explained that these contributions support the broader advancement of medical imaging technologies with potential benefits for healthcare and scientific research.
At the time of filing, the client had established an impressive record of scholarly achievement that included:
- 35 peer-reviewed journal articles (8 first-authored or co-first-authored)
- 8 first-authored abstracts
- 1,737 citations
- At least 26 completed peer reviews
We did not present these credentials as automatically proving extraordinary ability. Instead, we explained how an adjudicator could evaluate them in context. The publication record reflected sustained productivity in highly selective scientific venues, the citation record demonstrated that researchers around the world had independently relied upon the client's findings, the peer-review service showed that leading journals trusted the client's expertise to evaluate the work of other specialists, and the competitive research funding provided additional objective evidence that respected organizations considered the client's work scientifically valuable.
The petition further explained that the client's research had attracted substantial support from prestigious national and international funding organizations. Rather than presenting the funding as an accomplishment by itself, we demonstrated how these organizations supported research addressing important challenges in medical imaging, radiation detection, and advanced materials development. In this context, the funding reinforced that the client's research aligned with significant scientific priorities and possessed recognized practical value beyond the laboratory.
The petition also included 8 expert recommendation letters. These letters corroborated the objective evidence already established through the client's publications, citations, funding history, research influence, and peer-review service while providing additional expert perspectives regarding the significance of the client's scientific contributions.
“Clearly, [Client’s] contributions have been recognised for their prodigious impact in the field of advanced medical imaging.”
Ultimately, this approval reflected a strategy centered on context rather than statistics alone. We presented the client as an advanced medical imaging researcher whose work has contributed to more effective radiation detection technologies and next-generation medical imaging systems through sustained scientific innovation, independent recognition, and measurable influence on the work of researchers around the world. We congratulate the client on achieving EB-1A approval without RFE and look forward to the client's continued contributions to advancing medical imaging technologies.